Pure Global

Reagent Red Cells of Group A1 for ABO Reverse Grouping - India CDSCO Medical Device Registration

Reagent Red Cells of Group A1 for ABO Reverse Grouping is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000021_cf06a4f02171f91be99e79dc3f84208e_97e49aceb5bc811746f6bd4d28c6e659. This device is marketed under the brand name RPR. The license holder is TULIP DIAGNOSTICS PRIVATE LIMITED, and it is classified as Device Class Class D. The approving authority is Sub Zonal Goa.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
Reagent Red Cells of Group A1 for ABO Reverse Grouping
UID: MFG/IVD/2021/000021_cf06a4f02171f91be99e79dc3f84208e_97e49aceb5bc811746f6bd4d28c6e659

Brand Name

RPR

Device Class

Class D

Approving Authority

Sub Zonal Goa

Product Information

Matrix Erygen-A1 comprises of a 0.8% reagent red blood cells of A1 suspended in an isotonic medium containing a preservative which is employed in the confirmation of the results of forward grouping

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing